Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50+
SponsorJu Qiu

About this trial

This study uses the Physical Frailty Phenotype (PFP) as the diagnostic criterion for frailty and aims to explore the frailty screening scale FRAIL (The FRAIL Scale), Tilburg Frailty Index (TFI) and geriatric screening. Screening performance of Tool-8 (Geriatric-8, G-8) in breast cancer patients, to compare the predictive validity of different frailty screening scales for adverse health outcomes in breast cancer patients, and to select appropriate frailty screening methods for breast cancer patients in my country Screening scale.

Eligibility criteria

Qualifiers

Clinical diagnosis of breast cancer

Age ≥50 years old

the treatment plan discussed by MDT includes surgery and chemotherapy

can walk on their own (with the assistance of walking aids)

Disqualifiers

Communication disorders

Mental disorders that can't cooperate normally

Combined with other malignant tumours

Terminal stage of the disease

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

500 Participants
are grouped into 1 trial group

Sponsors and collaborators

Ju Qiu

Lead sponsor

Chongqing Medical University

Sponsor institution

Ministry of Education, China

Collaborator